158 related articles for article (PubMed ID: 22733902)
1. Utility of MRI features for differentiation of retroperitoneal fibrosis and lymphoma.
Rosenkrantz AB; Spieler B; Seuss CR; Stifelman MD; Kim S
AJR Am J Roentgenol; 2012 Jul; 199(1):118-26. PubMed ID: 22733902
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of Lymphoma Presenting as Retroperitoneal Mass and Retroperitoneal Fibrosis: Evaluation with Multidetector-row Computed Tomography.
Zhang S; Chen M; Li CM; Song GD; Liu Y
Chin Med J (Engl); 2017 Mar; 130(6):691-697. PubMed ID: 28303852
[TBL] [Abstract][Full Text] [Related]
3. Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study.
Bakir B; Yilmaz F; Turkay R; Ozel S; Bilgiç B; Velioglu A; Saka B; Salmaslioglu A
Radiology; 2014 Aug; 272(2):438-45. PubMed ID: 24702726
[TBL] [Abstract][Full Text] [Related]
4. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
Wehrli NE; Kim MJ; Matza BW; Melamed J; Taneja SS; Rosenkrantz AB
AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365
[TBL] [Abstract][Full Text] [Related]
5. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J
AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299
[TBL] [Abstract][Full Text] [Related]
6. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
7. Retroperitoneal fibrosis: typical and atypical manifestations.
Vivas I; Nicolás AI; Velázquez P; Elduayen B; Fernández-Villa T; Martínez-Cuesta A
Br J Radiol; 2000 Feb; 73(866):214-22. PubMed ID: 10884739
[TBL] [Abstract][Full Text] [Related]
8. High-grade bladder cancer: association of the apparent diffusion coefficient with metastatic disease: preliminary results.
Rosenkrantz AB; Mussi TC; Spieler B; Melamed J; Taneja SS; Huang WC
J Magn Reson Imaging; 2012 Jun; 35(6):1478-83. PubMed ID: 22282396
[TBL] [Abstract][Full Text] [Related]
9. Utility of diffusion-weighted MRI in characterization of adrenal lesions.
Miller FH; Wang Y; McCarthy RJ; Yaghmai V; Merrick L; Larson A; Berggruen S; Casalino DD; Nikolaidis P
AJR Am J Roentgenol; 2010 Feb; 194(2):W179-85. PubMed ID: 20093571
[TBL] [Abstract][Full Text] [Related]
10. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.
Riches SF; Payne GS; Morgan VA; Sandhu S; Fisher C; Germuska M; Collins DJ; Thompson A; deSouza NM
AJR Am J Roentgenol; 2009 Dec; 193(6):1583-91. PubMed ID: 19933651
[TBL] [Abstract][Full Text] [Related]
11. Malignant versus nonmalignant retroperitoneal fibrosis: differentiation with MR imaging.
Arrivé L; Hricak H; Tavares NJ; Miller TR
Radiology; 1989 Jul; 172(1):139-43. PubMed ID: 2740497
[TBL] [Abstract][Full Text] [Related]
12. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values.
Erbay G; Koc Z; Karadeli E; Kuzgunbay B; Goren MR; Bal N
Acta Radiol; 2012 Apr; 53(3):359-65. PubMed ID: 22334870
[TBL] [Abstract][Full Text] [Related]
14. Retroperitoneal liposarcoma: MR characteristics and pathological correlative analysis.
Song T; Shen J; Liang BL; Mai WW; Li Y; Guo HC
Abdom Imaging; 2007; 32(5):668-74. PubMed ID: 17387533
[TBL] [Abstract][Full Text] [Related]
15. Imaging appearance of fibrosing diseases of the retroperitoneum: can a definitive diagnosis be made?
Cohan RH; Shampain KL; Francis IR; Davenport MS; Stuart Wolf J; Marder W; Swartz RD
Abdom Radiol (NY); 2018 May; 43(5):1204-1214. PubMed ID: 28849414
[TBL] [Abstract][Full Text] [Related]
16. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
17. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.
Sandrasegaran K; Akisik FM; Lin C; Tahir B; Rajan J; Saxena R; Aisen AM
AJR Am J Roentgenol; 2009 Dec; 193(6):1556-60. PubMed ID: 19933647
[TBL] [Abstract][Full Text] [Related]
18. Perirenal involvement by retroperitoneal fibrosis: the usefulness of MRI to establish diagnosis.
Rominger MB; Kenney PJ
Urol Radiol; 1992; 13(3):173-6. PubMed ID: 1539409
[TBL] [Abstract][Full Text] [Related]
19. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features and prognostic analysis of retroperitoneal fibrosis in 32 patients].
An LM; Xu YF; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):265-9. PubMed ID: 22517001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
